{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:13:59Z","timestamp":1761844439339,"version":"3.40.5"},"reference-count":52,"publisher":"Tsinghua University Press","issue":"5","license":[{"start":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T00:00:00Z","timestamp":1417564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nano Res."],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12274-014-0635-4","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T07:56:53Z","timestamp":1417593413000},"page":"1505-1521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors"],"prefix":"10.26599","volume":"8","author":[{"given":"Mohammad-Ali","family":"Shahbazi","sequence":"first","affiliation":[]},{"given":"Neha","family":"Shrestha","sequence":"additional","affiliation":[]},{"given":"Ermei","family":"M\u00e4kil\u00e4","sequence":"additional","affiliation":[]},{"given":"Francisca","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Tom\u00e1s","family":"Ramos","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[]},{"given":"Jarno","family":"Salonen","sequence":"additional","affiliation":[]},{"given":"Jouni","family":"Hirvonen","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"11138","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"key":"635_CR1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.addr.2006.04.002","volume":"58","author":"A K Nowak","year":"2006","unstructured":"Nowak, A. K.; Lake, R. A.; Robinson, B. W. Combined chemoimmunotherapy of solid tumours: Improving vaccines. Adv. Drug Deliv. Rev. 2006, 58, 975\u2013990.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"635_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2011.05.025","volume":"155","author":"I H Lee","year":"2011","unstructured":"Lee, I. H.; An, S.; Yu, M. K.; Kwon, H. K.; Im, S. H.; Jon, S. Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates. J. Control. Release 2011, 155, 435\u2013441.","journal-title":"J. Control. Release"},{"key":"635_CR3","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1016\/j.biomaterials.2013.07.068","volume":"34","author":"O Molavi","year":"2013","unstructured":"Molavi, O.; Xiong, X. B.; Douglas, D.; Kneteman, N.; Nagata, S.; Pastan, I.; Chu, Q.; Lavasanifar, A.; Lai, R. Anti-cd30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma. Biomaterials 2013, 34, 8718\u20138725.","journal-title":"Biomaterials"},{"key":"635_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2010.05.001","volume":"63","author":"H Maeda","year":"2011","unstructured":"Maeda, H.; Matsumura, Y. Epr effect based drug design and clinical outlook for enhanced cancer chemotherapy. Adv. Drug Deliv. Rev. 2011, 63, 129\u2013130.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"635_CR5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","volume":"60","author":"J D Byrne","year":"2008","unstructured":"Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 2008, 60, 1615\u20131626.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"635_CR6","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/mp300016p","volume":"9","author":"N Chattopadhyay","year":"2012","unstructured":"Chattopadhyay, N.; Fonge, H.; Cai, Z.; Scollard, D.; Lechtman, E.; Done, S. J.; Pignol, J. P.; Reilly, R. M. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol. Pharmaceutics 2012, 9, 2168\u20132179.","journal-title":"Mol. Pharmaceutics"},{"key":"635_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biomaterials.2013.09.093","volume":"35","author":"Y M Lu","year":"2014","unstructured":"Lu, Y. M.; Huang, J. Y.; Wang, H.; Lou, X. F.; Liao, M. H.; Hong, L. J.; Tao, R. R.; Ahmed, M. M.; Shan, C. L.; Wang, X. L. et al. Targeted therapy of brain ischaemia using Fas ligand antibody conjugated peg-lipid nanoparticles. Biomaterials 2014, 35, 530\u2013537.","journal-title":"Biomaterials"},{"key":"635_CR8","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1021\/nn4018922","volume":"7","author":"L Fiandra","year":"2013","unstructured":"Fiandra, L.; Mazzucchelli, S.; De Palma, C.; Colombo, M.; Allevi, R.; Sommaruga, S.; Clementi, E.; Bellini, M.; Prosperi, D.; Corsi, F. Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. ACS Nano 2013, 7, 6092\u20136102.","journal-title":"ACS Nano"},{"key":"635_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","volume":"10","author":"L M Weiner","year":"2010","unstructured":"Weiner, L. M.; Surana, R.; Wang, S. Monoclonal antibodies: Versatile platforms for cancer immunotherapy. Nat. Rev. Immunol. 2010, 10, 317\u2013327.","journal-title":"Nat. Rev. Immunol."},{"key":"635_CR10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.nano.2011.01.001","volume":"7","author":"E Portnoy","year":"2011","unstructured":"Portnoy, E.; Lecht, S.; Lazarovici, P.; Danino, D.; Magdassi, S. Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging. Nanomedicine 2011, 7, 480\u2013488.","journal-title":"Nanomedicine"},{"key":"635_CR11","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1021\/nn2021293","volume":"5","author":"J M Berlin","year":"2011","unstructured":"Berlin, J. M.; Pham, T. T.; Sano, D.; Mohamedali, K. A.; Marcano, D. C.; Myers, J. N.; Tour, J. M. Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery. ACS Nano 2011, 5, 6643\u20136650.","journal-title":"ACS Nano"},{"key":"635_CR12","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/adma.201200776","volume":"24","author":"L Gu","year":"2012","unstructured":"Gu, L.; Ruff, L. E.; Qin, Z.; Corr, M.; Hedrick, S. M.; Sailor, M. J. Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic cd40 antibody. Adv. Mater. 2012, 24, 3981\u20133987.","journal-title":"Adv. Mater."},{"key":"635_CR13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0022-3565(25)21749-9","volume":"230","author":"L Illum","year":"1984","unstructured":"Illum, L.; Jones, P. D.; Baldwin, R. W.; Davis, S. S. Tissue distribution of poly(hexyl-2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts. J. Pharmacol. Exp. Ther. 1984, 230, 733\u2013736.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"635_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/bjc.1998.463","volume":"78","author":"M Chinol","year":"1998","unstructured":"Chinol, M.; Casalini, P.; Maggiolo, M.; Canevari, S.; Omodeo, E. S.; Caliceti, P.; Veronese, F. M.; Cremonesi, M.; Chiolerio, F.; Nardone, E. et al. Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. Br. J. Cancer 1998, 78, 189\u2013197.","journal-title":"Br. J. Cancer"},{"key":"635_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0161-5890(84)90115-9","volume":"21","author":"D Scott","year":"1984","unstructured":"Scott, D.; Nitecki, D. E.; Kindler, H.; Goodman, J. W. Immunogenicity of biotinylated hapten-avidin complexes. Mol. Immunol. 1984, 21, 1055\u20131060.","journal-title":"Mol. Immunol."},{"key":"635_CR16","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.biomaterials.2011.11.051","volume":"33","author":"J Zhao","year":"2012","unstructured":"Zhao, J.; Mi, Y.; Liu, Y.; Feng, S. S. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend. Biomaterials 2012, 33, 1948\u20131958.","journal-title":"Biomaterials"},{"key":"635_CR17","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1016\/j.biomaterials.2010.08.053","volume":"31","author":"Y Liu","year":"2010","unstructured":"Liu, Y.; Li, K.; Liu, B.; Feng, S. S. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 2010, 31, 9145\u20139155.","journal-title":"Biomaterials"},{"key":"635_CR18","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/smll.201100137","volume":"7","author":"E Venturelli","year":"2011","unstructured":"Venturelli, E.; Fabbro, C.; Chaloin, O.; Menard-Moyon, C.; Smulski, C. R.; Da Ros, T.; Kostarelos, K.; Prato, M.; Bianco, A. Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding. Small 2011, 7, 2179\u20132187.","journal-title":"Small"},{"key":"635_CR19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-8722-5-70","volume":"5","author":"M A Firer","year":"2012","unstructured":"Firer, M. A.; Gellerman, G. Targeted drug delivery for cancer therapy: The other side of antibodies. J. Hematol. Oncol. 2012, 5, 70.","journal-title":"J. Hematol. Oncol."},{"key":"635_CR20","first-page":"2724","volume":"17","author":"M Mitra","year":"2011","unstructured":"Mitra, M.; Misra, R.; Harilal, A.; Sahoo, S. K.; Krishnakumar, S. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mol. Vis. 2011, 17, 2724\u20132737.","journal-title":"Mol. Vis."},{"key":"635_CR21","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0002-9440(10)63570-5","volume":"163","author":"M J Winter","year":"2003","unstructured":"Winter, M. J.; Nagtegaal, I. D.; van Krieken, J. H.; Litvinov, S. V. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am. J. Pathol. 2003, 163, 2139\u20132148.","journal-title":"Am. J. Pathol."},{"key":"635_CR22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/1471-2407-12-501","volume":"12","author":"A Martowicz","year":"2012","unstructured":"Martowicz, A.; Spizzo, G.; Gastl, G.; Untergasser, G. Phenotype-dependent effects of epcam expression on growth and invasion of human breast cancer cell lines. BMC Cancer 2012, 12, 501.","journal-title":"BMC Cancer"},{"key":"635_CR23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1557\/jmr.2012.271","volume":"28","author":"H A Santos","year":"2013","unstructured":"Santos, H. A.; Bimbo, L. M.; Herranz, B.; Shahbazi, M. A.; Hirvonen, J.; Salonen, J. Nanostructured porous silicon in preclinical imaging: Moving from bench to bed side. J. Mater. Res. 2013, 28, 152\u2013164.","journal-title":"J. Mater. Res."},{"key":"635_CR24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/marc.201300868","volume":"35","author":"M A Shahbazi","year":"2014","unstructured":"Shahbazi, M. A.; Almeida, P. V.; M\u00e4kil\u00e4, E.; Correia, A.; Ferreira, M. P.; Kaasalainen, M.; Salonen, J.; Hirvonen, J.; Santos, H. A. Poly(methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization. Macromol. Rapid Commun. 2014, 35, 624\u2013629.","journal-title":"Macromol. Rapid Commun."},{"key":"635_CR25","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1016\/j.biomaterials.2013.06.052","volume":"34","author":"M A Shahbazi","year":"2013","unstructured":"Shahbazi, M. A.; Hamidi, M.; M\u00e4kil\u00e4, E. M.; Zhang, H.; Almeida, P. V.; Kaasalainen, M.; Salonen, J. J.; Hirvonen, J. T.; Santos, H. A. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. Biomaterials 2013, 34, 7776\u20137789.","journal-title":"Biomaterials"},{"key":"635_CR26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4161\/biom.22347","volume":"2","author":"M A Shahbazi","year":"2012","unstructured":"Shahbazi, M. A.; Herranz, B.; Santos, H. A. Nanostructured porous Si-based nanoparticles for targeted drug delivery. Biomatter 2012, 2, 296\u2013312.","journal-title":"Biomatter"},{"key":"635_CR27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4155\/tde.13.52","volume":"4","author":"T J Barnes","year":"2013","unstructured":"Barnes, T. J.; Jarvis, K. L.; Prestidge, C. A. Recent advances in porous silicon technology for drug delivery. Ther. Deliv. 2013, 4, 811\u2013823.","journal-title":"Ther. Deliv."},{"key":"635_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biomaterials.2013.09.033","volume":"35","author":"M Zhang","year":"2014","unstructured":"Zhang, M.; Xu, R.; Xia, X.; Yang, Y.; Gu, J.; Qin, G.; Liu, X.; Ferrari, M.; Shen, H. Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells. Biomaterials 2014, 35, 423\u2013431.","journal-title":"Biomaterials"},{"key":"635_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.colsurfb.2012.04.018","volume":"98","author":"O Tabasi","year":"2012","unstructured":"Tabasi, O.; Falamaki, C.; Khalaj, Z. Functionalized mesoporous silicon for targeted-drug-delivery. Colloids Surf. B-Biointerfaces 2012, 98, 18\u201325.","journal-title":"Colloids Surf. B-Biointerfaces"},{"key":"635_CR30","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/smll.201002300","volume":"7","author":"D P Ferris","year":"2011","unstructured":"Ferris, D. P.; Lu, J.; Gothard, C.; Yanes, R.; Thomas, C. R.; Olsen, J. C.; Stoddart, J. F.; Tamanoi, F.; Zink, J. I. Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells. Small 2011, 7, 1816\u20131826.","journal-title":"Small"},{"key":"635_CR31","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/smll.201201510","volume":"9","author":"R Xu","year":"2013","unstructured":"Xu, R.; Huang, Y.; Mai, J.; Zhang, G.; Guo, X.; Xia, X.; Koay, E. J.; Qin, G.; Erm, D. R.; Li, Q. et al. Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small 2013, 9, 1799\u20131808.","journal-title":"Small"},{"key":"635_CR32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/mp4002624","volume":"11","author":"J Rytk\u00f6nen","year":"2013","unstructured":"Rytk\u00f6nen, J.; Arukuusk, P.; Xu, W.; Kurrikoff, K.; Langel, U.; Lehto, V. P.; N\u00e4rv\u00e4nen, A. Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides. Mol. Pharmaceutics 2013, 11, 382\u2013390.","journal-title":"Mol. Pharmaceutics"},{"key":"635_CR33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/adhm.201200335","volume":"2","author":"E Secret","year":"2013","unstructured":"Secret, E.; Smith, K.; Dubljevic, V.; Moore, E.; Macardle, P.; Delalat, B.; Rogers, M. L.; Johns, T. G.; Durand, J. O.; Cunin, F. et al. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs. Adv. Health. Mater. 2013, 2, 718\u2013727.","journal-title":"Adv. Health. Mater."},{"key":"635_CR34","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.actbio.2009.12.043","volume":"6","author":"H A Santos","year":"2010","unstructured":"Santos, H. A.; Riikonen, J.; Salonen, J.; M\u00e4kil\u00e4, E.; Heikkil\u00e4, T.; Laaksonen, T.; Peltonen, L.; Lehto, V. P.; Hirvonen, J. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size. Acta Biomater. 2010, 6, 2721\u20132731.","journal-title":"Acta Biomater."},{"key":"635_CR35","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1016\/j.biomaterials.2014.04.104","volume":"35","author":"N Shrestha","year":"2014","unstructured":"Shrestha, N; Shahbazi, M. A; Ara\u00fajo, F; Zhang, H; M\u00e4kil\u00e4, E; Kauppila, J; Sarmento, B; Salonen, J; Hirvonen, J; Santos, H. A. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers. Biomaterials 2014, 35, 7172\u20137179.","journal-title":"Biomaterials"},{"key":"635_CR36","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1016\/j.biomaterials.2014.05.020","volume":"35","author":"M A Shahbazi","year":"2014","unstructured":"Shahbazi, M. A.; Almeida, P. V.; M\u00e4kil\u00e4, E.; Kaasalainen, N.; Salonen, J.; Hirvonen, J.; Santos, H. A. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering. Biomaterials 2014, 35, 7488\u20137500.","journal-title":"Biomaterials"},{"key":"635_CR37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1556-276X-7-311","volume":"7","author":"T Jalkanen","year":"2012","unstructured":"Jalkanen, T.; M\u00e4kil\u00e4, E.; Sakka, T.; Salonen, J.; Ogata, Y. H. Thermally promoted addition of undecylenic acid on thermally hydrocarbonized porous silicon optical reflectors. Nanoscale Res. Lett. 2012, 7, 311.","journal-title":"Nanoscale Res. Lett."},{"key":"635_CR38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1039\/C0NR00436G","volume":"3","author":"E Occhipinti","year":"2011","unstructured":"Occhipinti, E.; Verderio, P.; Natalello, A.; Galbiati, E.; Colombo, M.; Mazzucchelli, S.; Salvade, A.; Tortora, P.; Doglia, S. M.; Prosperi, D. Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles. Nanoscale 2011, 3, 387\u2013390.","journal-title":"Nanoscale"},{"key":"635_CR39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","volume":"148","author":"F Danhier","year":"2010","unstructured":"Danhier, F.; Feron, O.; Preat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 2010, 148, 135\u2013146.","journal-title":"J. Control. Release"},{"key":"635_CR40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1039\/C2BM00127F","volume":"1","author":"S Sasidharan","year":"2013","unstructured":"Sasidharan, S.; Jayasree, A.; Fazal, S.; Koyakutty, M.; Nair, S. V.; Menon, D. Ambient temperature synthesis of citrate stabilized and biofunctionalized, fluorescent calcium fluoride nanocrystals for targeted labeling of cancer cells. Biomater. Sci. 2013, 1, 294\u2013305.","journal-title":"Biomater. Sci."},{"key":"635_CR41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1745-7270.2007.00320.x","volume":"39","author":"J Kong","year":"2007","unstructured":"Kong, J.; Yu, S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim. Biophys. Sin. (Shanghai) 2007, 39, 549\u2013559.","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"635_CR42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2012.07.010","volume":"164","author":"I K Kwon","year":"2012","unstructured":"Kwon, I. K.; Lee, S. C.; Han, B.; Park, K. Analysis on the current status of targeted drug delivery to tumors. J. Control. Release 2012, 164, 108\u2013114.","journal-title":"J. Control. Release"},{"key":"635_CR43","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/mp4006408","volume":"11","author":"J Shen","year":"2014","unstructured":"Shen, J.; Sun, H.; Meng, Q.; Yin, Q.; Zhang, Z.; Yu, H.; Li, Y. Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA. Mol. Pharmaceutics 2014, 11, 3342\u20133351.","journal-title":"Mol. Pharmaceutics"},{"key":"635_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2013.00076","volume":"4","author":"U J Seidel","year":"2013","unstructured":"Seidel, U. J.; Schlegel, P.; Lang, P. Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies. Front. Immunol. 2013, 4, 76.","journal-title":"Front. Immunol."},{"key":"635_CR45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(09)60251-8","volume":"373","author":"L M Weiner","year":"2009","unstructured":"Weiner, L. M.; Dhodapkar, M. V.; Ferrone, S. Monoclonal antibodies for cancer immunotherapy. Lancet 2009, 373, 1033\u20131040.","journal-title":"Lancet"},{"key":"635_CR46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00262-014-1534-y","volume":"63","author":"F Chowdhury","year":"2014","unstructured":"Chowdhury, F.; Lode, H. N.; Cragg, M. S.; Glennie, M. J.; Gray, J. C. Development of immunomonitoring of antibody-dependent cellular cytotoxicity against neuroblastoma cells using whole blood. Cancer Immunol. Immunother. 2014, 63, 559\u2013569.","journal-title":"Cancer Immunol. Immunother."},{"key":"635_CR47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10555-005-6192-2","volume":"24","author":"A Iannello","year":"2005","unstructured":"Iannello, A.; Ahmad, A. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Cancer Metastasis Rev. 2005, 24, 487\u2013499.","journal-title":"Cancer Metastasis Rev."},{"key":"635_CR48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-0039.2003.00037.x","volume":"61","author":"N M Sorge van","year":"2003","unstructured":"van Sorge, N. M.; van der Pol, W. L.; van de Winkel, J. G. Fcgammar polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003, 61, 189\u2013202.","journal-title":"Tissue Antigens"},{"key":"635_CR49","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.3131876","volume":"240","author":"K A Smith","year":"1988","unstructured":"Smith, K. A. Interleukin-2: Inception, impact, and implications. Science 1988, 240, 1169\u20131176.","journal-title":"Science"},{"key":"635_CR50","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1634\/theoncologist.12-9-1084","volume":"12","author":"S E Strome","year":"2007","unstructured":"Strome, S. E.; Sausville, E. A.; Mann, D. A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects. Oncologist 2007, 12, 1084\u20131095.","journal-title":"Oncologist"},{"key":"635_CR51","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.22370","volume":"120","author":"Y Kawaguchi","year":"2007","unstructured":"Kawaguchi, Y.; Kono, K.; Mimura, K.; Sugai, H.; Akaike, H.; Fujii, H. Cetuximab induce antibody-dependent cellular cytotoxicity against egfr-expressing esophageal squamous cell carcinoma. Int. J. Cancer 2007, 120, 781\u2013787.","journal-title":"Int. J. Cancer"},{"key":"635_CR52","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1039\/c3nr33777d","volume":"5","author":"M H El-Dakdouki","year":"2013","unstructured":"El-Dakdouki, M. H.; Pure, E.; Huang, X. Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures. Nanoscale 2013, 5, 3895\u20133903.","journal-title":"Nanoscale"}],"container-title":["Nano Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12274-014-0635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12274-014-0635-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12274-014-0635-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:43:52Z","timestamp":1747176232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12274-014-0635-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,3]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1007\/s12274-014-0635-4","relation":{},"ISSN":["1998-0124","1998-0000"],"issn-type":[{"type":"print","value":"1998-0124"},{"type":"electronic","value":"1998-0000"}],"subject":[],"published":{"date-parts":[[2014,12,3]]}}}